Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a daily supplement ease perimenopause? new trial aims to find out

NCT ID NCT07361757

Symptom relief Sponsor: Qualia Life Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests three versions of a dietary supplement called Qualia Perimenopause in 120 women aged 40-55 who are experiencing perimenopause symptoms like hot flashes, mood swings, and sleep trouble. Participants take one capsule daily for 28 days and report their symptoms through online questionnaires. The goal is to see if the supplement reduces symptom burden and improves cognitive function and sleep.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Qualia Perimenopause (a multi-botanical dietary supplement)
What this could lead to
If it works, this could provide a natural option to ease common perimenopause symptoms like hot flashes, brain fog, and sleep problems.
What could go wrong
This is a small, early-stage trial with no placebo group, so results may be less reliable. The supplement may not work better than no treatment, and individual results can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 55 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: 1. Provide voluntary, written, informed consent to participate in the study 2. Agree to provide a valid cell phone number and are willing to receive communications through text 3. Can read and write English 4. Willing to not begin taking any new supplements during the study and continue taking any supplements they are currently using regularly 5. Willing to complete questionnaires, records, and diaries associated with the study 6. Healthy female participants ages 40-55 with menopause symptoms but not yet in menopause (period within last 12 months) 7. MRS total score ≥ 5 (preference given to higher score) Exclusion criteria: 1. Women who are pregnant, breastfeeding, or planning to become pregnant or start breastfeeding during the trial 2. Known food intolerances/allergy to any ingredients in the product 3. Having any of the following conditions: Psychiatric conditions, neurologic disorders, endocrine disorders, cancer 4. Having had a significant cardiovascular event in the past 6 months 5. Taking MAO inhibitors, SSRIs, or any other psychiatric or neurological medicines 6. On immunosuppressive therapy 7. Having had surgery within the past 6 weeks or upcoming planned surgery in the next few months 8. Adults lacking capacity to consent 9. Post-menopause (≥12 consecutive months without a period) 10. Taking medications: hormone replacement therapy; oral contraceptives; selective estrogen receptor modulators/aromatase inhibitors (e.g., Tamoxifen); sedatives/anxiolytics; blood thinners; insulin

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Peri-menopausal women are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Peri-menopausal women

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.